United States, Food and Drug Administration

Resource Information

The concept United States, Food and Drug Administration represents the subject, aboutness, idea or notion of resources found in University of Missouri Libraries.

"Just mayo" just isn't warns FDA
A review of the administration's fiscal year 2006 health care priorities : hearing before the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, February 17, 2005
A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003
Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization
Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997
Advancing regulatory science for medical countermeasure development : workshop summary
Advancing the discipline of regulatory science for medical product development : an update on progress and a forward-looking agenda : workshop summary
Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991
Agriculture Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1992 : P.L. 102-142, 105 Stat. 878, October 28, 1991
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1993 : P.L. 102-341, 106 Stat. 873, August 14, 1992
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1994 : P.L. 103-111, 107 Stat. 1046, October 21, 1993
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations for 1998 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Fifth Congress, first session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2016 : report (to accompany S. 1800)
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2017 : report (to accompany S. 2956)
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2017 : report together with dissenting and additional views (to accompany H.R. 5054)
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2021 : report together with minority views (to accompany H.R. 7610)
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations bill, 2022 : report together with minority views (to accompany H.R. 4356)
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1993 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Second Congress, second session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1994 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Third Congress, first session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 1999 : hearings before a subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Fifth Congress, second session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2011 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Eleventh Congress, second session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2012 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Twelfth Congress, first session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2013 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Twelfth Congress, second session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2015 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Thirteenth Congress, second session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2016 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Fourteenth Congress, first session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for 2020 : hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, One Hundred Sixteenth Congress, first session
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2008 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session on H.R. 3191/S. 1859, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for the fiscal year ending September 30, 2008, and for other purposes
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2009 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, second session on S. 3289, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for the fiscal year ending September 30, 2009, and for other purposes
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2010 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, first session on H.R. 2997/S. 1406, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2010, and for other purposes
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2011 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session on S. 3606, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2011, and for other purposes
Agriculture, Rural Development, Food and Drug Administration, and related agencies appropriations for fiscal year 2014 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Thirteenth Congress, first session on H.R. 2410/S. 1244, an act making appropriations for Agriculture, Rural Development, Food and Drug Administration, and related agencies programs for the fiscal year ending September 30, 2014, and for other purposes
Agriculture, Rural Development, and related agencies appropriations for fiscal year 2007 : hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, second session
Anesthesia machine failures : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, second session, September 26, 1984
Animal drug user fee agreements : advancing animal health for the public : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session ... February 27, 2013
Antibiotics, FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to congressional requesters
Assessing the safety of our nation's drug supply : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 9, 2007
Assessment of the Food and Drug Administration's handling of reports : on adverse reactions from the use of drugs
Banning of the drug Laetrile from interstate commerce by FDA : hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session ... July 12, 1977
Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015
Bottled water regulation : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, April 10, 1991
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Building a national framework for the establishment of regulatory science for drug development : workshop summary
CRS issue statement on agriculture appropriations
Cancer patient access to unapproved treatments : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996
Challenges for the FDA : the Future of Drug Safety : Workshop Summary
Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998
Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992
Delays in the FDA's food additive petition process and GRAS affirmation process : hearings before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 22 and 29, 1995
Dietary Supplement Health and Education Act : is the FDA trying to change the intent of Congress? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, March 25, 1999
Dietary Supplement Safety Act : how is the Food and Drug Administration doing 10 years later? : hearing before the Oversight of Government Management, the Federal Workforce, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, second session, June 8, 2004
Drug Industry Antitrust Act : hearings before the Antitrust Subcommittee (Subcommittee No. 5) of the Committee on the Judiciary, House of Representatives, Eighty-seventh Congress, second session, on H.R. 6245, a bill to amend and supplement the antitrust laws with respect to the manufacture and distribution of drugs, and for other purposes, May 17, 18, 23, and 24, 1962
Drug compounding : FDA authority and possible issues for Congress
Drug compounding, FDA has taken steps to implement compounding law, but some states and stakeholders reported challenges : report to Congressional Committees
Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981
Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ..
Drug safety : a side-by-side comparison of bills in the 110th Congress
Drug safety : most drugs withdrawn in recent years had greater health risks for women
Drug safety and effectiveness : issues and action options after FDA approval
Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate
Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives
Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007
Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Ephedra : who is protecting the American consumers? : hearing before the Oversight of Government Management, Restructuring, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Seventh Congress, second session, October 8, 2002
Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
Excluding substandard canned pineapple from the United States : Food and Drug Administration, Department of Health, Education and Welfare
FDA Advisory Committee conflict of interest
FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995
FDA FY2009 appropriations
FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999
FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990
FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992
FDA authority to oversee private laboratories that analyze imported FDA-regulated food
FDA drug approval--a lengthy process that delays the availability of important new drugs : report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
FDA final rule restricting the sale and distribution of cigarettes and smokeless tobacco
FDA foreign drug inspection program : a system at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, November 1, 2007
FDA guidance regarding the promotion of off-label uses of drugs : legal issues
FDA human medical product user fee programs : in brief
FDA legislation in the 110th Congress : a guide to S. 1082 and H.R. 2900
FDA management and enforcement : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, September 12, 1991
FDA medical device reviews, evaluation is needed to assure requests for additional information follow a least burdensome approach : report to congressional requesters
FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
FDA medical product user fee reauthorization : in brief
FDA mismanagement : regulation of soft contact lenses : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; Ninety-seventh Congress, first session ; May 29 and June 2, 1981
FDA oversight : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982
FDA oversight--food inspection : hearings, Ninety-second Congress, first session ..
FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997
FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987
FDA proposals to permit the use of disease-specific health claims on food labels : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, December 10, 1987
FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997
FDA regulation of cosmetics and personal care products
FDA regulation of medical devices
FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995
FDA regulation of ribavirin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, May 28, 1987
FDA regulation of soft contact lenses : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, December 12, 1980
FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session. September 25, 1972
FDA regulation of tobacco products
FDA regulation of tobacco products
FDA regulation of tobacco products : a policy and legal analysis
FDA resources : comprehensive assessment of staffing, facilities, and equipment needed : report to congressional requesters
FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives
FDA tobacco regulation : the Family Smoking Prevention and Tobacco Control Act of 2009
FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651
FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow : report to the Congress
FDA's authority to ensure that drugs prescribed to children are safe and effective
FDA's authority to regulate drug compounding : a legal analysis
FDA's continuing failure to regulate health claims for foods : hearings before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, first session, October 31 and November 9, 1989
FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session
FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; One Hundred Second Congress, first session ; March 7 and June 5, 1991
FDA's oversight of the 1982 canned salmon recalls : report to the Chairman, Subcommittee on Oversights and Investigations, Committee on Energy and Commerce, House of Representatives
FDA's prescription to over-the-counter drug switch : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session on the Food and Drug Administration's policies and procedures in switching drugs from prescription to over-the-counter status, June 6, 1983
FDA's regulation of Carcinogenic additives : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, June 24, 1987
FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983
FDA's regulation of food imports : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, June 16, 1993
FDA's regulation of the dietary supplement L-tryptophan : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, July 18, 1991
FDA's regulation of the drug "triazure" : hearing before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session. October 27, 1976
FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984
FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987
FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
FDA's role in protecting the public health : examining FDA's review of safety and efficacy concerns in anti-depressant use by children ; hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; One Hundred Eighth Congress, second session ; September 23, 2004
FDA's role in the evaluation of Avandia's safety : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007
FY2016 agriculture and related agencies appropriations : in brief
FY2016 appropriations : selected federal food safety agencies
FY2017 agriculture and related agencies appropriations : in brief
Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712)
Federal food, drug, and cosmetic act : with amendments
Federal pesticide registration program : is it protecting the public and the environment adequately from pesticide hazards?, Environmental Protection Agency, Food and Drug Administration (HEW) : report to the Congress
Federal protection for human research subjects : an analysis of the Common Rule and its interactions with FDA regulations and the HIPAA privacy rule
Federal regulation of medical devices : problems still to be overcome : report to the Congress
Financial disclosure system for employees of the Food and Drug Administration needs tightening : report to the Congress
Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities
Food and Drug Administration : regulation of tobacco products : report to Congressional requesters
Food and Drug Administration : revenue information on certain companies participating in the Medical Device User Fee Program
Food and Drug Administration FY2011 budget and appropriations
Food and Drug Administration Modernization Act of 1997--the provisions
Food and Drug Administration Revitalization Act : P.L. 101-635, 104 Stat. 4583, November 28, 1990
Food and Drug Administration act : hearing, Ninety-second Congress, second session, on H.R. 15315 Ninety-second Congress, second session, on H.R. 15315 ... June 9, 1972
Food and Drug Administration appropriations for FY2010
Food and Drug Administration management concerns : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998
Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives
Food and Drug Administration practice and procedure, 1975 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate; Ninety-fourth Congress, first session; on examination of the history of Food and Drug Administration's regulatory efforts with the Dalkon Shield, and the procedures they use in considering various drugs given to animals that may be consumed by the American people; January 28, 1975--the Dalkon Shield; January 29, 1975--Bureau of Veterinary Medicine and Bureau of Foods
Food and Drug Administration practice and procedure, 1976 : joint hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session ... July 20, 1976
Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate; One Hundred Tenth Congress, first session; special hearing: June 1, 2007; Salt Lake City, Utah
Food and Drug Administration's food labeling regulation, its effect on small business : hearings before the Subcommittee on Special Small Business Problems of the Committee on Small Business, House of Representatives, Ninety-fifth Congress, second session, Washington, D.C., July 13, August 3, 1977, and March 15, 1978
Food and Drug Administration's program for regulating imported products needs improving, Department of Health, Education, and Welfare, Department of the Treasury : report to the Congress
Food and Drug Administration's regulation of dietary supplements : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, July 20, 1993
Food and Drug Administration, laboratory analysis of product samples needs to be more timely : report to the Secretary of Health and Human Services
Food and Drug Administration, resources for Division of Scientific Investigations have been reduced : fact sheet for the Chairman, Special Committee on Aging, United States Senate
Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters
Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995
Food and drug administration : its programs--problems--resources
Food import inspection : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session, July 19 and September 28, 1989
Food recalls and other FDA administrative enforcement actions
Food safety : foodborne illness and selected recalls of FDA-regulated foods
Food safety issues : FDA judicial enforcement actions
Food safety, FDA's efforts to evaluate and respond to business concerns regarding the produce rule
Food safety: federal efforts to manage the risk of arsenic in rice : report to the Ranking Member, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, Committee on Appropriations, House of Representatives
Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2135 ... May 19, 1992
Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Administration, July 17, 1991
Generic Drug Enforcement Act of 1992 : P.L. 102-282, 106 Stat. 149, May 13, 1992
Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991
Genetically modified foods : experts view regimen of safety tests as adequate, but FDA's evaluation process could be enhanced
H.R. 3504: Pesticide Monitoring Improvements Act
Hard to swallow : FDA enforcement program for imported food : a staff report
Hollow government : the Food and Drug Administration : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, July 25, 1991
How FDA approves drugs and regulates their safety and effectiveness
How accurate is the FDA's monitoring of supplements like ephedra? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999
How do we fix our ailing food safety system? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 11, 2009
Impact of chemical and related drug products and Federal regulatory processes : hearings before the Subcommittee on Dairy and Poultry of the Committee on Agriculture, House of Representatives, Ninety-fifth Congress, first session, May 23, 24, and 25, 1977
Impact of medical device regulation on jobs and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, February 17, 2011
Implementation of the Food and Drug Administration Modernization Act of 1997 : hearing before the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 7, 1998
Imported drugs : U.S.-EU (European Union) mutual recognition agreement on drug inspections : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, October 2, 1998
Information technology, FDA has taken steps to address challenges but needs a comprehensive strategic plan : report to congressional committees
Keeping America's families safe : reforming the food safety system : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eleventh Congress, first session, on examining keeping America's families safe, focusing on reforming the food safety system, October 22, 2009
Lack of authority hampers attempts to increase cosmetic safety : report to the Congress
Legal issues associated with FDA standards of identity : in brief
Legislative changes and administrative improvements should be considered for FDA to better protect the public from adulterated food products : report to the Chairman, Subcommittee on Oversight and Investigations, House Committee on Energy and Commerce
Legislative history of the Biologics Price Competition and Innovation Act of 2009
Medicaid Pharmaceutical Home Act of 2018 : report together with additional views (to accompany H.R. 5808) (including cost estimate of the Congressional Budget Office)
Medical device regulation : the FDA's neglected child : an oversight report on FDA implementation of the Medical Device Amendments of 1976 : report of the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives
Medical device user fees : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session, on H.R. 4728, a bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a device application fee, and for other purposes, July 14, 1994
Medical devices : protecting patients and promoting innovation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... November 15, 2011
Medical devices : technological innovation and patient/provider perspectives : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, May 30, 1997
Medical technology development and commercialization : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, November 2, 1995
Mercury in medicine--are we taking unnecessary risks? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, July 18, 2000
More effective action needed to control abuse and diversion in methadone treatment programs : Food and Drug Administration, Department of Health, Education, and Welfare, Drug Enforcement Administration, Department of Justice : report to the Congress
Naked reverse : Secretary Sullivan's rescission of his delegation of investigative authority to the Inspector General : a staff report
Nomination : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session on Mark McClellan, of the District of Columbia, to be Commissioner of Food and Drugs, October 7, 2002
Nomination : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, second session, on Jane E. Henney, of New Mexico, to be Commissioner of Food and Drugs, Department of Health and Human Services, September 2, 1998
Nomination of Andrew von Eschenbach and Paul DeCamp : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on Andrew von Eschenbach, of Texas, to be Commissioner of Food and Drugs, Department of Health and Human Services ; Paul DeCamp, of Virginia, to be Administrator of the Wage and Hour Division, Department of Labor, August 1, 2006
Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office)
Oversight of FTC's shared responsibilities : hearing before the Subcommittee on Transportation and Hazardous Materials of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, concerning advertising and labeling issues with the Bureau of Alcohol, Tobacco, and Firearms, the Environmental Protection Agency, and the Food and Drug Administration, November 21, 1991
Oversight of NIH and FDA : bioethics and the adequacy of informed consent : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, May 8, 1997
Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996
Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
Patient access to alternative treatments : beyond the FDA : hearings before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, February 4 and 12, 1998
Patient safety and anticancer drugs, 1983 : hearing before the Committee on labor and Human Resources, United States Senate, Ninety-eighth Congress, first session on examination of the effects of anticancer drugs in the treatment of cancer patients, June 23, 1983
Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House and Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990
Pipeline drugs : proposed remedies for relief in the Drug Patent Term Restoration Review Procedure Act of 1999 : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, first session, on S. 1172 ... August 4, 1999
Potential transmission of spongiform encephalopathies to humans : the Food and Drug Administration's (FDA) ruminant to ruminant feed ban and the safety of other products : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, January 29, 1997
Preclinical and clinical testing by the pharmaceutical industry, 1975[-1976] : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out ..
Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on examination of the process of drug testing and FDA's role in the process, October 11, 1979
President's budget blueprint seeks changes for public health service agencies
Problems with FDA monitoring for animal drug residues : is our milk safe? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, August 5, 1992
Problems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid : hearing before the Human Resources and Intergovernmental Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991
Processed fruits and vegetables: potentially adulterated products need to be better controlled, sanitation in some plants needs improvement : report to the Congress [on the] Agricultural Marketing Service ... [and the] Food and Drug Administration ...
Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991
Public hazards from unsatisfactory medical diagnostic products, Food and Drug Administration, Department of Health, Education, and Welfare : report to the Congress
Public health effectiveness of the FDA 510(k) clearance process : balancing patient safety and innovation : workshop report
Public health effectiveness of the FDA 510(k) clearance process : measuring postmarket performance and other select topics : workshop report
Punitive damages : tort reform and FDA defenses : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, first session, on S. 671 ... S. 672 ... April 4 and July 26, 1995
Quality of scientific evidence in FDA regulatory decisions : the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978
RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990
Raising health awareness through examining benign brain tumor cancer, alpha one, and breast implant issues : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, November 15, 2001
Reauthorization of the Prescription Drug User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997
Recall procedures of the Food and Drug Administration : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. March 29, 1971
Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993
Regulation of cigarettes and smokeless tobacco under the Federal Food, Drug, and Cosmetic Act
Regulation of the food additive aspartame : Food and Drug Administration, Department of Health, Education, and Welfare : report
Regulatory exclusivity reform in the 115th Congress
Regulatory policies of the Food and Drug Administration : Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, second session, June 9, 1970
Reinventing regulation of drugs and medical devices
Reinventing the regulation of cancer drugs : accelerating approval and expanding access
Reinventing the regulation of drugs made from biotechnology
Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996
Riegel v. Medtronic, Inc. : federal preemption of state tort law regarding medical devices with FDA premarket approval
Role of commissioner of food and drugs : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current commissioner of the Food and Drug Administration, March 6, 1991
Safety of the U.S. food supply : continuing concerns over the Food and Drug Administration's food-recall process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 19, 2018
Seafood safety : FDA needs to improve oversight of imported seafood and better leverage limited resources : report to congressional committees
Selected resources on federal oversight of compounding pharmacies
Senate confirmation of the FDA commissioner ; and reauthorization of research activities by ADAMHA : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3909 ... March 6, 1986
Soft contact lens solutions : oversight of FDA : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representative, Ninety-sixth Congress, second session, July 1, 1980
Staff report on Sanofi's strategic use of third parties to influence the FDA
Sulfites : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 27, 1985
The FDA Commission : the delegation of authority to state and local officials
The FDA FY2009 budget
The FDA medical device user fee program : MDUFA IV reauthorization
The FDA medical device user fee program : MDUFA IV reauthorization
The FDA's authority to recall products
The FDA's regulation of silicone breast implants : a staff report
The Food and Drug Administration : budget and statutory history, FY1980-FY2007
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007
The Impact of the Food and Drug Administration on our society : a fiftieth anniversary panorama
The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives; One Hundred Tenth Congress, first session; February 13, March 22, 2007
The future of drug safety : promoting and protecting the health of the public
The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
The need for FDA regulation of tobacco : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate; One Hundred Tenth Congress, first session; on examining S. 625, to protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products; February 27, 2007
The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995
The regulation of animal drugs by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, first session, July 24 and 25, 1985
The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982
The regulation of pharmaceuticals : balancing the benefits and risks
To assess the impact of proposed FDA user fees on small business : hearing before the Committee on Small Business, United States Senate, One Hundred First Congress, first session ... June 13, 1989
Tobacco legislation and the Food and Drug Administration and smokeless tobacco issues in the proposed settlement : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Fifth Congress, second session, March 17, 1998
U.S.-South Korea beef dispute : issues and status
U.S.-South Korea beef dispute : negotiations and status
U.S.-South Korea beef dispute : negotiations and status
Unlocking the cures for America's most deadly diseases : hearing before the Subcommittee on Space, Science, and Competitiveness of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Fourteenth Congress, first session, July 14, 2015
Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives
Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives ; Ninety-third Congress, second session[-Ninety-fourth Congress, first session]
User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992
When diets turn deadly : consumer safety and weight-loss supplements : hearing before the Oversight of Government Management, Restructuring, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Seventh Congress, second session, July 31, 2002
Year 2000 computing crisis: readiness of Medicare and the health care sector: : testimony before the Subcommittee on Oversight and Investigations and the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives

Embed

Settings

Select options that apply then copy and paste the RDF/HTML data fragment to include in your application

Embed this data in a secure (HTTPS) page:

Layout options: Carousel Grid List Card

Include data citation:

<div class="citation" vocab="http://schema.org/"> Data from <a href="http://link.library.missouri.edu/resource/u8AYUQ28YRY/">United States, Food and Drug Administration</a> - <a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></div>

Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements

Preview

Cite Data - Experimental

Data Citation of the Concept United States, Food and Drug Administration

Copy and paste the following RDF/HTML data fragment to cite this resource

<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.missouri.edu/resource/u8AYUQ28YRY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.missouri.edu/resource/u8AYUQ28YRY/">United States, Food and Drug Administration</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.missouri.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></span></span></span></span></div>

United States, Food and Drug Administration Resource Information The concept United States, Food and Drug Administration represents the subject, aboutness, idea or notion of resources found in University of Missouri Libraries.

269 Items that share the Concept United States, Food and Drug Administration

Context

Subject of

United States, Food and Drug Administration

Resource Information

The concept United States, Food and Drug Administration represents the subject, aboutness, idea or notion of resources found in University of Missouri Libraries.